189 related articles for article (PubMed ID: 19060914)
1. Effect of sugar positions in ginsenosides and their inhibitory potency on Na+/K+-ATPase activity.
Chen RJ; Chung TY; Li FY; Lin NH; Tzen JT
Acta Pharmacol Sin; 2009 Jan; 30(1):61-9. PubMed ID: 19060914
[TBL] [Abstract][Full Text] [Related]
2. Steroid-like compounds in Chinese medicines promote blood circulation via inhibition of Na+/K+ -ATPase.
Chen RJ; Chung TY; Li FY; Yang WH; Jinn TR; Tzen JT
Acta Pharmacol Sin; 2010 Jun; 31(6):696-702. PubMed ID: 20523340
[TBL] [Abstract][Full Text] [Related]
3. Active ingredients in Chinese medicines promoting blood circulation as Na+/K+ -ATPase inhibitors.
Chen RJ; Jinn TR; Chen YC; Chung TY; Yang WH; Tzen JT
Acta Pharmacol Sin; 2011 Feb; 32(2):141-51. PubMed ID: 21293466
[TBL] [Abstract][Full Text] [Related]
4. Active compounds in Chinese herbs and medicinal animal products which promote blood circulation via inhibition of Na+, K+-ATPase.
Tzen JT; Chen RJ; Chung TY; Chen YC; Lin NH
Chang Gung Med J; 2010; 33(2):126-36. PubMed ID: 20438664
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of panaxatriol derivatives as Na
Wu Q; Chen P; Tu G; Li M; Pan B; Guo Y; Zhai J; Fu H
Bioorg Med Chem Lett; 2018 Sep; 28(17):2885-2889. PubMed ID: 30049579
[TBL] [Abstract][Full Text] [Related]
6. Magnesium lithospermate B possesses inhibitory activity on Na+,K+-ATPase and neuroprotective effects against ischemic stroke.
Tzen JT; Jinn TR; Chen YC; Li FY; Cheng FC; Shi LS; She HKh; Chen BC; Hsieh V; Tu ML
Acta Pharmacol Sin; 2007 May; 28(5):609-15. PubMed ID: 17439716
[TBL] [Abstract][Full Text] [Related]
7. Revisiting the binding kinetics and inhibitory potency of cardiac glycosides on Na
Noël F; Azalim P; do Monte FM; Quintas LEM; Katz A; Karlish SJD
J Pharmacol Toxicol Methods; 2018; 94(Pt 2):64-72. PubMed ID: 30244071
[TBL] [Abstract][Full Text] [Related]
8. Interaction between cardiotonic steroids and Na,K-ATPase. Effects of pH and ouabain-induced changes in enzyme conformation.
Cornelius F; Mahmmoud YA
Biochemistry; 2009 Oct; 48(42):10056-65. PubMed ID: 19778013
[TBL] [Abstract][Full Text] [Related]
9. A structural view on the functional importance of the sugar moiety and steroid hydroxyls of cardiotonic steroids in binding to Na,K-ATPase.
Cornelius F; Kanai R; Toyoshima C
J Biol Chem; 2013 Mar; 288(9):6602-16. PubMed ID: 23341448
[TBL] [Abstract][Full Text] [Related]
10. Interactions between cardiac glycosides and sodium/potassium-ATPase: three-dimensional structure-activity relationship models for ligand binding to the E2-Pi form of the enzyme versus activity inhibition.
Paula S; Tabet MR; Ball WJ
Biochemistry; 2005 Jan; 44(2):498-510. PubMed ID: 15641774
[TBL] [Abstract][Full Text] [Related]
11. A comparative study on anticoagulant activities of three Chinese herbal medicines from the genus Panax and anticoagulant activities of ginsenosides Rg1 and Rg2.
Li CT; Wang HB; Xu BJ
Pharm Biol; 2013 Aug; 51(8):1077-80. PubMed ID: 23742679
[TBL] [Abstract][Full Text] [Related]
12. 2-Methoxy-3,8,9-trihydroxy coumestan: a new synthetic inhibitor of Na+,K+-ATPase with an original mechanism of action.
Pôças ES; Costa PR; da Silva AJ; Noël F
Biochem Pharmacol; 2003 Dec; 66(11):2169-76. PubMed ID: 14609741
[TBL] [Abstract][Full Text] [Related]
13. The non-gastric H,K-ATPase as a tool to study the ouabain-binding site in Na,K-ATPase.
De Pont JJ; Swarts HG; Karawajczyk A; Schaftenaar G; Willems PH; Koenderink JB
Pflugers Arch; 2009 Jan; 457(3):623-34. PubMed ID: 18324411
[TBL] [Abstract][Full Text] [Related]
14. Isolation and characterization of an endogenous Na+,K(+)-ATPase-specific inhibitor from pig urine.
Tamura M; Harris TM; Konishi F; Inagami T
Eur J Biochem; 1993 Jan; 211(1-2):317-27. PubMed ID: 8381085
[TBL] [Abstract][Full Text] [Related]
15. Binding of ouabain and marinobufagenin leads to different structural changes in Na,K-ATPase and depends on the enzyme conformation.
Klimanova EA; Petrushanko IY; Mitkevich VA; Anashkina AA; Orlov SN; Makarov AA; Lopina OD
FEBS Lett; 2015 Sep; 589(19 Pt B):2668-74. PubMed ID: 26297827
[TBL] [Abstract][Full Text] [Related]
16. Ouabain interactions with the H5-H6 hairpin of the Na,K-ATPase reveal a possible inhibition mechanism via the cation binding domain.
Palasis M; Kuntzweiler TA; Argüello JM; Lingrel JB
J Biol Chem; 1996 Jun; 271(24):14176-82. PubMed ID: 8662895
[TBL] [Abstract][Full Text] [Related]
17. Interaction of palytoxin and cardiac glycosides on erythrocyte membrane and (Na+ + K+) ATPase.
Ozaki H; Nagase H; Urakawa N
Eur J Biochem; 1985 Oct; 152(2):475-80. PubMed ID: 2865137
[TBL] [Abstract][Full Text] [Related]
18. Characterization, quantitation, similarity evaluation and combination with Na
Bai Y; Zhu W; Xu Y; Xie Z; Akihisa T; Manosroi J; Sun H; Feng F; Liu W; Zhang J
Bioorg Chem; 2019 Jun; 87():265-275. PubMed ID: 30908969
[TBL] [Abstract][Full Text] [Related]
19. 17beta-O-Aminoalkyloximes of 5beta-androstane-3beta,14beta-diol with digitalis-like activity: synthesis, cardiotonic activity, structure-activity relationships, and molecular modeling of the Na(+),K(+)-ATPase receptor.
Cerri A; Almirante N; Barassi P; Benicchio A; Fedrizzi G; Ferrari P; Micheletti R; Quadri L; Ragg E; Rossi R; Santagostino M; Schiavone A; Serra F; Zappavigna MP; Melloni P
J Med Chem; 2000 Jun; 43(12):2332-49. PubMed ID: 10882359
[TBL] [Abstract][Full Text] [Related]
20. Comparison of low-molecular-weight plasma and urine Na-K-ATPase inhibitors/hypertensive factors.
Gonick HC; Weiler EW; Prins BA; Purdy RE
J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S69-71. PubMed ID: 7508033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
